<p>A therapeutic composition for treating and/or preventing retinal disorder includes intravitreally or transsclerally administered erythropoietin.</p>
申请公布号
EP2037952(A4)
申请公布日期
2010.08.04
申请号
EP20070720997
申请日期
2007.04.28
申请人
SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES;PHILADELPHIA HEALTH AND EDUCATION CORPORATION D/B/A;VIMETRICS LLC
